Oaktree Acquisition Corp III Life Sciences (OACC) Return on Equity (ROE) (2024 - 2026)

Oaktree Acquisition Corp III Life Sciences (OACC) Return on Equity (ROE) from Sep 30, 2024 to Mar 31, 2026. The TTM Oaktree Acquisition Corp III Life Sciences (OACC) Return on Equity (ROE) is 0.71%. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.